nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—POLE4—embryo—malignant glioma	0.0204	0.0741	CbGeAlD
Cladribine—POLE2—embryo—malignant glioma	0.0179	0.0647	CbGeAlD
Cladribine—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.0178	0.0477	CcSEcCtD
Cladribine—POLE3—embryo—malignant glioma	0.00991	0.0359	CbGeAlD
Cladribine—POLE4—central nervous system—malignant glioma	0.00945	0.0342	CbGeAlD
Cladribine—Opportunistic infection—Temozolomide—malignant glioma	0.00886	0.0238	CcSEcCtD
Cladribine—NR5A1—brainstem—malignant glioma	0.0088	0.0319	CbGeAlD
Cladribine—RRM2B—telencephalon—malignant glioma	0.00853	0.0309	CbGeAlD
Cladribine—Pulmonary fibrosis—Carmustine—malignant glioma	0.0084	0.0225	CcSEcCtD
Cladribine—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00811	0.0218	CcSEcCtD
Cladribine—POLE3—telencephalon—malignant glioma	0.00806	0.0292	CbGeAlD
Cladribine—Lung infiltration—Carmustine—malignant glioma	0.00787	0.0211	CcSEcCtD
Cladribine—Myelosuppression—Carmustine—malignant glioma	0.00787	0.0211	CcSEcCtD
Cladribine—Altered state of consciousness—Temozolomide—malignant glioma	0.00773	0.0207	CcSEcCtD
Cladribine—Myelosuppression—Temozolomide—malignant glioma	0.00761	0.0204	CcSEcCtD
Cladribine—POLE—embryo—malignant glioma	0.00756	0.0274	CbGeAlD
Cladribine—Adenosine monophosphate—PIM1—malignant glioma	0.00751	1	CrCbGaD
Cladribine—POLE4—brain—malignant glioma	0.0075	0.0272	CbGeAlD
Cladribine—Lymphopenia—Temozolomide—malignant glioma	0.00697	0.0187	CcSEcCtD
Cladribine—RRM2B—medulla oblongata—malignant glioma	0.0067	0.0243	CbGeAlD
Cladribine—POLE3—medulla oblongata—malignant glioma	0.00634	0.023	CbGeAlD
Cladribine—RRM2—embryo—malignant glioma	0.00623	0.0226	CbGeAlD
Cladribine—Febrile neutropenia—Carmustine—malignant glioma	0.00614	0.0165	CcSEcCtD
Cladribine—RRM2B—midbrain—malignant glioma	0.00613	0.0222	CbGeAlD
Cladribine—RRM2B—spinal cord—malignant glioma	0.00598	0.0217	CbGeAlD
Cladribine—Febrile neutropenia—Temozolomide—malignant glioma	0.00593	0.0159	CcSEcCtD
Cladribine—Oral candidiasis—Carmustine—malignant glioma	0.00581	0.0156	CcSEcCtD
Cladribine—POLE3—midbrain—malignant glioma	0.00579	0.021	CbGeAlD
Cladribine—POLA1—retina—malignant glioma	0.00576	0.0209	CbGeAlD
Cladribine—POLE3—spinal cord—malignant glioma	0.00565	0.0205	CbGeAlD
Cladribine—Oral candidiasis—Temozolomide—malignant glioma	0.00562	0.0151	CcSEcCtD
Cladribine—Cyst—Carmustine—malignant glioma	0.00552	0.0148	CcSEcCtD
Cladribine—PNP—central nervous system—malignant glioma	0.00522	0.0189	CbGeAlD
Cladribine—Thrombosis—Carmustine—malignant glioma	0.00522	0.014	CcSEcCtD
Cladribine—Interstitial lung disease—Carmustine—malignant glioma	0.00522	0.014	CcSEcCtD
Cladribine—Interstitial lung disease—Temozolomide—malignant glioma	0.00504	0.0135	CcSEcCtD
Cladribine—RRM2B—central nervous system—malignant glioma	0.00485	0.0176	CbGeAlD
Cladribine—Herpes zoster—Temozolomide—malignant glioma	0.00474	0.0127	CcSEcCtD
Cladribine—RRM2B—cerebellum—malignant glioma	0.00474	0.0172	CbGeAlD
Cladribine—POLE3—central nervous system—malignant glioma	0.00458	0.0166	CbGeAlD
Cladribine—RRM1—retina—malignant glioma	0.00457	0.0166	CbGeAlD
Cladribine—POLE3—cerebellum—malignant glioma	0.00448	0.0162	CbGeAlD
Cladribine—NR5A1—central nervous system—malignant glioma	0.00444	0.0161	CbGeAlD
Cladribine—NR5A1—cerebellum—malignant glioma	0.00434	0.0157	CbGeAlD
Cladribine—Petechiae—Temozolomide—malignant glioma	0.00434	0.0116	CcSEcCtD
Cladribine—Extravasation—Carmustine—malignant glioma	0.00423	0.0114	CcSEcCtD
Cladribine—RRM1—telencephalon—malignant glioma	0.00421	0.0153	CbGeAlD
Cladribine—PNP—brain—malignant glioma	0.00415	0.015	CbGeAlD
Cladribine—DCK—embryo—malignant glioma	0.00402	0.0146	CbGeAlD
Cladribine—RRM2B—brain—malignant glioma	0.00385	0.014	CbGeAlD
Cladribine—Pulmonary embolism—Carmustine—malignant glioma	0.00369	0.00991	CcSEcCtD
Cladribine—Injection site reaction—Carmustine—malignant glioma	0.00367	0.00985	CcSEcCtD
Cladribine—POLE3—brain—malignant glioma	0.00364	0.0132	CbGeAlD
Cladribine—Musculoskeletal pain—Temozolomide—malignant glioma	0.00361	0.00969	CcSEcCtD
Cladribine—Pulmonary embolism—Temozolomide—malignant glioma	0.00357	0.00958	CcSEcCtD
Cladribine—Depressed level of consciousness—Carmustine—malignant glioma	0.00357	0.00957	CcSEcCtD
Cladribine—DCK—retina—malignant glioma	0.00355	0.0129	CbGeAlD
Cladribine—NR5A1—brain—malignant glioma	0.00353	0.0128	CbGeAlD
Cladribine—Candida infection—Carmustine—malignant glioma	0.00353	0.00946	CcSEcCtD
Cladribine—POLE—central nervous system—malignant glioma	0.0035	0.0127	CbGeAlD
Cladribine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00345	0.00925	CcSEcCtD
Cladribine—POLE—cerebellum—malignant glioma	0.00342	0.0124	CbGeAlD
Cladribine—Candida infection—Temozolomide—malignant glioma	0.00341	0.00914	CcSEcCtD
Cladribine—Aplastic anaemia—Temozolomide—malignant glioma	0.00335	0.00899	CcSEcCtD
Cladribine—Neoplasm—Carmustine—malignant glioma	0.00334	0.00896	CcSEcCtD
Cladribine—RRM1—medulla oblongata—malignant glioma	0.00331	0.012	CbGeAlD
Cladribine—DCK—telencephalon—malignant glioma	0.00327	0.0118	CbGeAlD
Cladribine—Neoplasm—Temozolomide—malignant glioma	0.00323	0.00866	CcSEcCtD
Cladribine—Sepsis—Carmustine—malignant glioma	0.0032	0.0086	CcSEcCtD
Cladribine—Phlebitis—Carmustine—malignant glioma	0.00311	0.00835	CcSEcCtD
Cladribine—Swelling—Carmustine—malignant glioma	0.00304	0.00816	CcSEcCtD
Cladribine—RRM1—midbrain—malignant glioma	0.00302	0.011	CbGeAlD
Cladribine—RRM1—spinal cord—malignant glioma	0.00295	0.0107	CbGeAlD
Cladribine—POLA1—cerebellum—malignant glioma	0.00295	0.0107	CbGeAlD
Cladribine—Vascular purpura—Temozolomide—malignant glioma	0.0029	0.00777	CcSEcCtD
Cladribine—Hepatic failure—Temozolomide—malignant glioma	0.00288	0.00774	CcSEcCtD
Cladribine—RRM2—central nervous system—malignant glioma	0.00288	0.0104	CbGeAlD
Cladribine—SLC22A1—telencephalon—malignant glioma	0.00279	0.0101	CbGeAlD
Cladribine—POLE—brain—malignant glioma	0.00278	0.0101	CbGeAlD
Cladribine—Purpura—Temozolomide—malignant glioma	0.00269	0.00721	CcSEcCtD
Cladribine—DCK—medulla oblongata—malignant glioma	0.00257	0.00931	CbGeAlD
Cladribine—Ataxia—Carmustine—malignant glioma	0.00252	0.00677	CcSEcCtD
Cladribine—Ataxia—Temozolomide—malignant glioma	0.00244	0.00654	CcSEcCtD
Cladribine—POLA1—brain—malignant glioma	0.00239	0.00867	CbGeAlD
Cladribine—RRM1—central nervous system—malignant glioma	0.00239	0.00867	CbGeAlD
Cladribine—Muscular weakness—Carmustine—malignant glioma	0.00236	0.00635	CcSEcCtD
Cladribine—DCK—midbrain—malignant glioma	0.00235	0.00851	CbGeAlD
Cladribine—RRM1—cerebellum—malignant glioma	0.00234	0.00847	CbGeAlD
Cladribine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00233	0.00626	CcSEcCtD
Cladribine—DCK—spinal cord—malignant glioma	0.00229	0.0083	CbGeAlD
Cladribine—RRM2—brain—malignant glioma	0.00229	0.00829	CbGeAlD
Cladribine—Muscular weakness—Temozolomide—malignant glioma	0.00228	0.00613	CcSEcCtD
Cladribine—Pancytopenia—Carmustine—malignant glioma	0.0022	0.00591	CcSEcCtD
Cladribine—Sweating increased—Temozolomide—malignant glioma	0.00218	0.00585	CcSEcCtD
Cladribine—Neutropenia—Carmustine—malignant glioma	0.00217	0.00581	CcSEcCtD
Cladribine—Pancytopenia—Temozolomide—malignant glioma	0.00213	0.00571	CcSEcCtD
Cladribine—Neutropenia—Temozolomide—malignant glioma	0.00209	0.00562	CcSEcCtD
Cladribine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00208	0.00558	CcSEcCtD
Cladribine—Pneumonia—Carmustine—malignant glioma	0.00208	0.00558	CcSEcCtD
Cladribine—Renal failure—Carmustine—malignant glioma	0.00203	0.00545	CcSEcCtD
Cladribine—Urinary tract infection—Carmustine—malignant glioma	0.00201	0.00539	CcSEcCtD
Cladribine—Pneumonia—Temozolomide—malignant glioma	0.00201	0.00539	CcSEcCtD
Cladribine—Infestation—Temozolomide—malignant glioma	0.002	0.00536	CcSEcCtD
Cladribine—Infestation NOS—Temozolomide—malignant glioma	0.002	0.00536	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00198	0.00531	CcSEcCtD
Cladribine—Urinary tract infection—Temozolomide—malignant glioma	0.00194	0.00521	CcSEcCtD
Cladribine—RRM1—brain—malignant glioma	0.0019	0.00688	CbGeAlD
Cladribine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00189	0.00507	CcSEcCtD
Cladribine—Haemoglobin—Carmustine—malignant glioma	0.00186	0.005	CcSEcCtD
Cladribine—DCK—central nervous system—malignant glioma	0.00186	0.00673	CbGeAlD
Cladribine—Haemorrhage—Carmustine—malignant glioma	0.00185	0.00498	CcSEcCtD
Cladribine—Oedema peripheral—Carmustine—malignant glioma	0.00183	0.0049	CcSEcCtD
Cladribine—ABCG2—telencephalon—malignant glioma	0.00182	0.00661	CbGeAlD
Cladribine—Connective tissue disorder—Carmustine—malignant glioma	0.00182	0.00489	CcSEcCtD
Cladribine—DCK—cerebellum—malignant glioma	0.00182	0.00658	CbGeAlD
Cladribine—Haemoglobin—Temozolomide—malignant glioma	0.0018	0.00483	CcSEcCtD
Cladribine—Haemorrhage—Temozolomide—malignant glioma	0.00179	0.00481	CcSEcCtD
Cladribine—Pharyngitis—Temozolomide—malignant glioma	0.00178	0.00477	CcSEcCtD
Cladribine—Urinary tract disorder—Temozolomide—malignant glioma	0.00177	0.00475	CcSEcCtD
Cladribine—Oedema peripheral—Temozolomide—malignant glioma	0.00177	0.00474	CcSEcCtD
Cladribine—Connective tissue disorder—Temozolomide—malignant glioma	0.00176	0.00473	CcSEcCtD
Cladribine—Urethral disorder—Temozolomide—malignant glioma	0.00176	0.00471	CcSEcCtD
Cladribine—Eye disorder—Carmustine—malignant glioma	0.00173	0.00465	CcSEcCtD
Cladribine—Erythema multiforme—Temozolomide—malignant glioma	0.00169	0.00455	CcSEcCtD
Cladribine—Eye disorder—Temozolomide—malignant glioma	0.00167	0.00449	CcSEcCtD
Cladribine—Cardiac disorder—Temozolomide—malignant glioma	0.00166	0.00446	CcSEcCtD
Cladribine—Arrhythmia—Carmustine—malignant glioma	0.00166	0.00445	CcSEcCtD
Cladribine—Alopecia—Carmustine—malignant glioma	0.00164	0.0044	CcSEcCtD
Cladribine—Angiopathy—Temozolomide—malignant glioma	0.00163	0.00436	CcSEcCtD
Cladribine—Mental disorder—Carmustine—malignant glioma	0.00162	0.00436	CcSEcCtD
Cladribine—Immune system disorder—Temozolomide—malignant glioma	0.00162	0.00434	CcSEcCtD
Cladribine—Mediastinal disorder—Temozolomide—malignant glioma	0.00162	0.00433	CcSEcCtD
Cladribine—Malnutrition—Carmustine—malignant glioma	0.00161	0.00433	CcSEcCtD
Cladribine—Erythema—Carmustine—malignant glioma	0.00161	0.00433	CcSEcCtD
Cladribine—Chills—Temozolomide—malignant glioma	0.00161	0.00432	CcSEcCtD
Cladribine—SLC22A1—central nervous system—malignant glioma	0.00158	0.00574	CbGeAlD
Cladribine—Alopecia—Temozolomide—malignant glioma	0.00158	0.00425	CcSEcCtD
Cladribine—Mental disorder—Temozolomide—malignant glioma	0.00157	0.00421	CcSEcCtD
Cladribine—Back pain—Carmustine—malignant glioma	0.00156	0.00419	CcSEcCtD
Cladribine—Erythema—Temozolomide—malignant glioma	0.00156	0.00419	CcSEcCtD
Cladribine—Malnutrition—Temozolomide—malignant glioma	0.00156	0.00419	CcSEcCtD
Cladribine—Back pain—Temozolomide—malignant glioma	0.00151	0.00405	CcSEcCtD
Cladribine—Anaemia—Carmustine—malignant glioma	0.00149	0.004	CcSEcCtD
Cladribine—DCK—brain—malignant glioma	0.00148	0.00535	CbGeAlD
Cladribine—Ill-defined disorder—Temozolomide—malignant glioma	0.00145	0.00388	CcSEcCtD
Cladribine—Anaemia—Temozolomide—malignant glioma	0.00144	0.00387	CcSEcCtD
Cladribine—ABCG2—medulla oblongata—malignant glioma	0.00143	0.00519	CbGeAlD
Cladribine—Malaise—Temozolomide—malignant glioma	0.00141	0.00378	CcSEcCtD
Cladribine—Chest pain—Carmustine—malignant glioma	0.00137	0.00369	CcSEcCtD
Cladribine—Myalgia—Carmustine—malignant glioma	0.00137	0.00369	CcSEcCtD
Cladribine—Anxiety—Carmustine—malignant glioma	0.00137	0.00368	CcSEcCtD
Cladribine—Cough—Temozolomide—malignant glioma	0.00136	0.00365	CcSEcCtD
Cladribine—Confusional state—Carmustine—malignant glioma	0.00133	0.00357	CcSEcCtD
Cladribine—Myalgia—Temozolomide—malignant glioma	0.00133	0.00356	CcSEcCtD
Cladribine—Arthralgia—Temozolomide—malignant glioma	0.00133	0.00356	CcSEcCtD
Cladribine—Anxiety—Temozolomide—malignant glioma	0.00132	0.00355	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00132	0.00354	CcSEcCtD
Cladribine—Oedema—Carmustine—malignant glioma	0.00132	0.00354	CcSEcCtD
Cladribine—Discomfort—Temozolomide—malignant glioma	0.00131	0.00352	CcSEcCtD
Cladribine—ABCG2—midbrain—malignant glioma	0.00131	0.00475	CbGeAlD
Cladribine—Infection—Carmustine—malignant glioma	0.00131	0.00351	CcSEcCtD
Cladribine—Thrombocytopenia—Carmustine—malignant glioma	0.00129	0.00346	CcSEcCtD
Cladribine—Tachycardia—Carmustine—malignant glioma	0.00129	0.00345	CcSEcCtD
Cladribine—Confusional state—Temozolomide—malignant glioma	0.00128	0.00345	CcSEcCtD
Cladribine—ABCG2—spinal cord—malignant glioma	0.00128	0.00463	CbGeAlD
Cladribine—Oedema—Temozolomide—malignant glioma	0.00127	0.00342	CcSEcCtD
Cladribine—Infection—Temozolomide—malignant glioma	0.00126	0.00339	CcSEcCtD
Cladribine—SLC22A1—brain—malignant glioma	0.00126	0.00456	CbGeAlD
Cladribine—Anorexia—Carmustine—malignant glioma	0.00126	0.00337	CcSEcCtD
Cladribine—Nervous system disorder—Temozolomide—malignant glioma	0.00125	0.00335	CcSEcCtD
Cladribine—Thrombocytopenia—Temozolomide—malignant glioma	0.00125	0.00335	CcSEcCtD
Cladribine—Skin disorder—Temozolomide—malignant glioma	0.00124	0.00332	CcSEcCtD
Cladribine—Hypotension—Carmustine—malignant glioma	0.00123	0.0033	CcSEcCtD
Cladribine—Hyperhidrosis—Temozolomide—malignant glioma	0.00123	0.0033	CcSEcCtD
Cladribine—Anorexia—Temozolomide—malignant glioma	0.00121	0.00326	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0012	0.00322	CcSEcCtD
Cladribine—Insomnia—Carmustine—malignant glioma	0.00119	0.0032	CcSEcCtD
Cladribine—Paraesthesia—Carmustine—malignant glioma	0.00118	0.00318	CcSEcCtD
Cladribine—Dyspnoea—Carmustine—malignant glioma	0.00117	0.00315	CcSEcCtD
Cladribine—Somnolence—Carmustine—malignant glioma	0.00117	0.00314	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00116	0.00311	CcSEcCtD
Cladribine—Insomnia—Temozolomide—malignant glioma	0.00115	0.00309	CcSEcCtD
Cladribine—Decreased appetite—Carmustine—malignant glioma	0.00115	0.00307	CcSEcCtD
Cladribine—Paraesthesia—Temozolomide—malignant glioma	0.00114	0.00307	CcSEcCtD
Cladribine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00114	0.00305	CcSEcCtD
Cladribine—Dyspnoea—Temozolomide—malignant glioma	0.00114	0.00305	CcSEcCtD
Cladribine—Somnolence—Temozolomide—malignant glioma	0.00113	0.00304	CcSEcCtD
Cladribine—Pain—Carmustine—malignant glioma	0.00113	0.00302	CcSEcCtD
Cladribine—Constipation—Carmustine—malignant glioma	0.00113	0.00302	CcSEcCtD
Cladribine—Decreased appetite—Temozolomide—malignant glioma	0.00111	0.00297	CcSEcCtD
Cladribine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0011	0.00295	CcSEcCtD
Cladribine—Fatigue—Temozolomide—malignant glioma	0.0011	0.00295	CcSEcCtD
Cladribine—Constipation—Temozolomide—malignant glioma	0.00109	0.00292	CcSEcCtD
Cladribine—Pain—Temozolomide—malignant glioma	0.00109	0.00292	CcSEcCtD
Cladribine—Feeling abnormal—Carmustine—malignant glioma	0.00109	0.00291	CcSEcCtD
Cladribine—Gastrointestinal pain—Carmustine—malignant glioma	0.00108	0.00289	CcSEcCtD
Cladribine—Feeling abnormal—Temozolomide—malignant glioma	0.00105	0.00282	CcSEcCtD
Cladribine—Abdominal pain—Carmustine—malignant glioma	0.00104	0.0028	CcSEcCtD
Cladribine—Body temperature increased—Carmustine—malignant glioma	0.00104	0.0028	CcSEcCtD
Cladribine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00104	0.00279	CcSEcCtD
Cladribine—ABCG2—cerebellum—malignant glioma	0.00101	0.00367	CbGeAlD
Cladribine—Urticaria—Temozolomide—malignant glioma	0.00101	0.00271	CcSEcCtD
Cladribine—Abdominal pain—Temozolomide—malignant glioma	0.00101	0.0027	CcSEcCtD
Cladribine—Body temperature increased—Temozolomide—malignant glioma	0.00101	0.0027	CcSEcCtD
Cladribine—Hypersensitivity—Carmustine—malignant glioma	0.000971	0.00261	CcSEcCtD
Cladribine—Asthenia—Carmustine—malignant glioma	0.000945	0.00254	CcSEcCtD
Cladribine—Hypersensitivity—Temozolomide—malignant glioma	0.000938	0.00252	CcSEcCtD
Cladribine—Asthenia—Temozolomide—malignant glioma	0.000913	0.00245	CcSEcCtD
Cladribine—Diarrhoea—Carmustine—malignant glioma	0.000901	0.00242	CcSEcCtD
Cladribine—Pruritus—Temozolomide—malignant glioma	0.000901	0.00242	CcSEcCtD
Cladribine—Dizziness—Carmustine—malignant glioma	0.000871	0.00234	CcSEcCtD
Cladribine—Diarrhoea—Temozolomide—malignant glioma	0.000871	0.00234	CcSEcCtD
Cladribine—Dizziness—Temozolomide—malignant glioma	0.000842	0.00226	CcSEcCtD
Cladribine—Vomiting—Carmustine—malignant glioma	0.000838	0.00225	CcSEcCtD
Cladribine—Rash—Carmustine—malignant glioma	0.000831	0.00223	CcSEcCtD
Cladribine—Dermatitis—Carmustine—malignant glioma	0.00083	0.00223	CcSEcCtD
Cladribine—Headache—Carmustine—malignant glioma	0.000825	0.00222	CcSEcCtD
Cladribine—ABCG2—brain—malignant glioma	0.000823	0.00298	CbGeAlD
Cladribine—Vomiting—Temozolomide—malignant glioma	0.000809	0.00217	CcSEcCtD
Cladribine—Rash—Temozolomide—malignant glioma	0.000803	0.00215	CcSEcCtD
Cladribine—Dermatitis—Temozolomide—malignant glioma	0.000802	0.00215	CcSEcCtD
Cladribine—Headache—Temozolomide—malignant glioma	0.000798	0.00214	CcSEcCtD
Cladribine—Nausea—Carmustine—malignant glioma	0.000783	0.0021	CcSEcCtD
Cladribine—Nausea—Temozolomide—malignant glioma	0.000756	0.00203	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000211	0.000614	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000211	0.000612	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00021	0.00061	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—BIRC5—malignant glioma	0.000209	0.000607	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000208	0.000603	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000207	0.000601	CbGpPWpGaD
Cladribine—POLA1—S Phase—MYC—malignant glioma	0.000206	0.000599	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—CDKN2B—malignant glioma	0.000206	0.000597	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000205	0.000595	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—BIRC5—malignant glioma	0.000204	0.000594	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000204	0.000594	CbGpPWpGaD
Cladribine—PNP—Metabolism—NCOR1—malignant glioma	0.000204	0.000593	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000203	0.000589	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP2B6—malignant glioma	0.000202	0.000587	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN2A—malignant glioma	0.000202	0.000586	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000202	0.000586	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.0002	0.000581	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TERT—malignant glioma	0.000198	0.000575	CbGpPWpGaD
Cladribine—RRM2—Metabolism—IDH1—malignant glioma	0.000198	0.000574	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—BIRC5—malignant glioma	0.000196	0.00057	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MDM2—malignant glioma	0.000196	0.000569	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NCOR1—malignant glioma	0.000195	0.000567	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—BCHE—malignant glioma	0.000194	0.000564	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000193	0.000561	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CAV1—malignant glioma	0.000192	0.000557	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000191	0.000556	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SPHK1—malignant glioma	0.000191	0.000556	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TERT—malignant glioma	0.00019	0.000552	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000189	0.000549	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—MMP9—malignant glioma	0.000188	0.000548	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP2C18—malignant glioma	0.000187	0.000544	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000186	0.00054	CbGpPWpGaD
Cladribine—DCK—Metabolism—IDH1—malignant glioma	0.000185	0.000537	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GSTT1—malignant glioma	0.000184	0.000535	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—SLC6A3—malignant glioma	0.000182	0.00053	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000181	0.000526	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—BCHE—malignant glioma	0.000181	0.000525	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00018	0.000523	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000179	0.00052	CbGpPWpGaD
Cladribine—DCK—Metabolism—SPHK1—malignant glioma	0.000179	0.000519	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000179	0.000519	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP2C18—malignant glioma	0.000175	0.000509	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CG—malignant glioma	0.000175	0.000508	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000174	0.000507	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS1—malignant glioma	0.000172	0.000501	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—SLC6A3—malignant glioma	0.00017	0.000494	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—VEGFA—malignant glioma	0.000169	0.000492	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PPARG—malignant glioma	0.000169	0.00049	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—STAT3—malignant glioma	0.000168	0.000487	CbGpPWpGaD
Cladribine—PNP—Metabolism—CAV1—malignant glioma	0.000166	0.000483	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—MYC—malignant glioma	0.000165	0.000481	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—BRCA2—malignant glioma	0.000163	0.000475	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2B—malignant glioma	0.000162	0.000471	CbGpPWpGaD
Cladribine—RRM1—Metabolism—BCHE—malignant glioma	0.00016	0.000466	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SLC5A5—malignant glioma	0.000158	0.00046	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000158	0.000458	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000156	0.000454	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CD—malignant glioma	0.000154	0.000446	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—MYC—malignant glioma	0.000153	0.000444	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—EGFR—malignant glioma	0.000152	0.000443	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTT1—malignant glioma	0.000151	0.00044	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CG—malignant glioma	0.000151	0.00044	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000151	0.00044	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NOTCH1—malignant glioma	0.000148	0.00043	CbGpPWpGaD
Cladribine—PNP—Metabolism—PPARG—malignant glioma	0.000146	0.000425	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000145	0.000422	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TNF—malignant glioma	0.000145	0.000422	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000145	0.000421	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—KRAS—malignant glioma	0.000144	0.000418	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS1—malignant glioma	0.000142	0.000413	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000142	0.000412	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTT1—malignant glioma	0.000142	0.000411	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—BIRC5—malignant glioma	0.00014	0.000406	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—PPARG—malignant glioma	0.00014	0.000406	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MYC—malignant glioma	0.000137	0.000397	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2A—malignant glioma	0.000135	0.000394	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TERT—malignant glioma	0.000135	0.000393	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000135	0.000393	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000134	0.000389	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CB—malignant glioma	0.000134	0.000389	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—COX8A—malignant glioma	0.000133	0.000388	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CD—malignant glioma	0.000133	0.000387	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGS2—malignant glioma	0.000133	0.000386	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS1—malignant glioma	0.000133	0.000386	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—COX8A—malignant glioma	0.000132	0.000384	CbGpPWpGaD
Cladribine—RRM2—Metabolism—BCHE—malignant glioma	0.000132	0.000384	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MDM2—malignant glioma	0.000131	0.000382	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SLC5A5—malignant glioma	0.00013	0.000379	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2A—malignant glioma	0.00013	0.000378	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000129	0.000375	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000129	0.000374	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GSTP1—malignant glioma	0.000127	0.000371	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MDM2—malignant glioma	0.000126	0.000366	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CAT—malignant glioma	0.000124	0.000361	CbGpPWpGaD
Cladribine—DCK—Metabolism—BCHE—malignant glioma	0.000123	0.000358	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000123	0.000358	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—COX8A—malignant glioma	0.000123	0.000357	CbGpPWpGaD
Cladribine—DCK—Metabolism—SLC5A5—malignant glioma	0.000122	0.000354	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00012	0.00035	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000119	0.000346	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NCOR1—malignant glioma	0.000117	0.000341	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CB—malignant glioma	0.000116	0.000337	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTEN—malignant glioma	0.000116	0.000336	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGS2—malignant glioma	0.000115	0.000334	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ASMT—malignant glioma	0.000113	0.00033	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000113	0.000329	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—malignant glioma	0.000112	0.000326	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ASMT—malignant glioma	0.000112	0.000326	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000112	0.000326	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000108	0.000315	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—malignant glioma	0.000108	0.000314	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000108	0.000313	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—BCAN—malignant glioma	0.000107	0.00031	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—BCAN—malignant glioma	0.000105	0.000307	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GSTP1—malignant glioma	0.000105	0.000305	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ASMT—malignant glioma	0.000105	0.000304	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000105	0.000304	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000104	0.000302	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000104	0.000301	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000103	0.000299	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—malignant glioma	0.000103	0.000298	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CAT—malignant glioma	0.000102	0.000297	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000101	0.000293	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000101	0.000292	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000101	0.000292	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTEN—malignant glioma	0.0001	0.000292	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.91e-05	0.000288	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—BRAF—malignant glioma	9.9e-05	0.000288	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—malignant glioma	9.85e-05	0.000286	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—BCAN—malignant glioma	9.83e-05	0.000286	CbGpPWpGaD
Cladribine—DCK—Metabolism—GSTP1—malignant glioma	9.81e-05	0.000285	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.8e-05	0.000285	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NCOR1—malignant glioma	9.65e-05	0.00028	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.6e-05	0.000279	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CAV1—malignant glioma	9.55e-05	0.000278	CbGpPWpGaD
Cladribine—DCK—Metabolism—CAT—malignant glioma	9.55e-05	0.000277	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—malignant glioma	9.26e-05	0.000269	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—BRAF—malignant glioma	9.22e-05	0.000268	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MYC—malignant glioma	9.18e-05	0.000267	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.14e-05	0.000266	CbGpPWpGaD
Cladribine—DCK—Metabolism—NCOR1—malignant glioma	9.02e-05	0.000262	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MDM2—malignant glioma	8.98e-05	0.000261	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—malignant glioma	8.81e-05	0.000256	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CG—malignant glioma	8.7e-05	0.000253	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IDH2—malignant glioma	8.59e-05	0.00025	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IDH2—malignant glioma	8.5e-05	0.000247	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—malignant glioma	8.4e-05	0.000244	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MDM2—malignant glioma	8.29e-05	0.000241	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—RAF1—malignant glioma	8.26e-05	0.00024	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CA—malignant glioma	8.16e-05	0.000237	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2B6—malignant glioma	8.08e-05	0.000235	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2B6—malignant glioma	7.99e-05	0.000232	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—malignant glioma	7.97e-05	0.000232	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IDH2—malignant glioma	7.93e-05	0.00023	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CAV1—malignant glioma	7.86e-05	0.000229	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MDM2—malignant glioma	7.73e-05	0.000225	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—RAF1—malignant glioma	7.7e-05	0.000224	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CD—malignant glioma	7.65e-05	0.000222	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—malignant glioma	7.53e-05	0.000219	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2B6—malignant glioma	7.45e-05	0.000217	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IDH1—malignant glioma	7.39e-05	0.000215	CbGpPWpGaD
Cladribine—DCK—Metabolism—CAV1—malignant glioma	7.35e-05	0.000214	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IDH1—malignant glioma	7.31e-05	0.000213	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—malignant glioma	7.23e-05	0.00021	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CG—malignant glioma	7.16e-05	0.000208	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SPHK1—malignant glioma	7.15e-05	0.000208	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CA—malignant glioma	7.07e-05	0.000206	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SPHK1—malignant glioma	7.07e-05	0.000206	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—malignant glioma	7.02e-05	0.000204	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2C18—malignant glioma	7e-05	0.000204	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2C18—malignant glioma	6.93e-05	0.000201	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—malignant glioma	6.91e-05	0.000201	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IDH1—malignant glioma	6.81e-05	0.000198	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CG—malignant glioma	6.69e-05	0.000195	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—malignant glioma	6.67e-05	0.000194	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CB—malignant glioma	6.67e-05	0.000194	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—malignant glioma	6.6e-05	0.000192	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SPHK1—malignant glioma	6.59e-05	0.000192	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—malignant glioma	6.46e-05	0.000188	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2C18—malignant glioma	6.46e-05	0.000188	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CD—malignant glioma	6.3e-05	0.000183	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—malignant glioma	6.28e-05	0.000182	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CD—malignant glioma	5.89e-05	0.000171	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—malignant glioma	5.78e-05	0.000168	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTEN—malignant glioma	5.76e-05	0.000167	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTT1—malignant glioma	5.66e-05	0.000165	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTT1—malignant glioma	5.61e-05	0.000163	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—malignant glioma	5.52e-05	0.000161	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CB—malignant glioma	5.49e-05	0.00016	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—malignant glioma	5.44e-05	0.000158	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS1—malignant glioma	5.31e-05	0.000154	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS1—malignant glioma	5.25e-05	0.000153	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTT1—malignant glioma	5.22e-05	0.000152	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—malignant glioma	5.15e-05	0.00015	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CB—malignant glioma	5.13e-05	0.000149	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—malignant glioma	5.08e-05	0.000148	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—BCHE—malignant glioma	4.93e-05	0.000143	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS1—malignant glioma	4.9e-05	0.000142	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—BCHE—malignant glioma	4.88e-05	0.000142	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC5A5—malignant glioma	4.87e-05	0.000142	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC5A5—malignant glioma	4.82e-05	0.00014	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTEN—malignant glioma	4.74e-05	0.000138	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—BCHE—malignant glioma	4.55e-05	0.000132	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC5A5—malignant glioma	4.5e-05	0.000131	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.49e-05	0.00013	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.44e-05	0.000129	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTEN—malignant glioma	4.43e-05	0.000129	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.14e-05	0.00012	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CA—malignant glioma	4.06e-05	0.000118	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTP1—malignant glioma	3.93e-05	0.000114	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTP1—malignant glioma	3.89e-05	0.000113	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CAT—malignant glioma	3.82e-05	0.000111	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CAT—malignant glioma	3.78e-05	0.00011	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTP1—malignant glioma	3.62e-05	0.000105	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOR1—malignant glioma	3.61e-05	0.000105	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOR1—malignant glioma	3.57e-05	0.000104	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CAT—malignant glioma	3.52e-05	0.000102	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CA—malignant glioma	3.35e-05	9.73e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOR1—malignant glioma	3.33e-05	9.67e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—malignant glioma	3.32e-05	9.65e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CA—malignant glioma	3.13e-05	9.09e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CAV1—malignant glioma	2.94e-05	8.55e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CAV1—malignant glioma	2.91e-05	8.46e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—malignant glioma	2.73e-05	7.95e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CAV1—malignant glioma	2.71e-05	7.89e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CG—malignant glioma	2.68e-05	7.79e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CG—malignant glioma	2.65e-05	7.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—malignant glioma	2.59e-05	7.52e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—malignant glioma	2.56e-05	7.44e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—malignant glioma	2.55e-05	7.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CG—malignant glioma	2.47e-05	7.18e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—malignant glioma	2.39e-05	6.93e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CD—malignant glioma	2.36e-05	6.85e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CD—malignant glioma	2.33e-05	6.77e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CD—malignant glioma	2.17e-05	6.31e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CB—malignant glioma	2.05e-05	5.97e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—malignant glioma	2.03e-05	5.91e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CB—malignant glioma	2.03e-05	5.91e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—malignant glioma	2.01e-05	5.85e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CB—malignant glioma	1.89e-05	5.5e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—malignant glioma	1.88e-05	5.45e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTEN—malignant glioma	1.77e-05	5.16e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTEN—malignant glioma	1.76e-05	5.1e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTEN—malignant glioma	1.64e-05	4.76e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CA—malignant glioma	1.25e-05	3.64e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.24e-05	3.6e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.15e-05	3.36e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—malignant glioma	1.02e-05	2.97e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—malignant glioma	1.01e-05	2.94e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—malignant glioma	9.43e-06	2.74e-05	CbGpPWpGaD
